464152-37-2

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-(2-methoxypyridin-4-yl)acetate is used as an intermediate in the synthesis of organic compounds for the development of pharmaceuticals. Its unique structure and properties make it a valuable building block in the production of various medications, contributing to the advancement of healthcare.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-(2-methoxypyridin-4-yl)acetate serves as a key intermediate in the synthesis of agrochemicals. Its incorporation into these products helps improve crop protection and yield, supporting sustainable agriculture.
Used in Food Industry:
Methyl 2-(2-methoxypyridin-4-yl)acetate is also utilized as a flavoring agent in the food industry. Its distinct taste profile adds depth and complexity to various food products, enhancing the overall sensory experience for consumers.

Upstream product

• 100848-70-2 2-methoxy-4-methyl-pyridine 
• 616-38-6 carbonic acid dimethyl ester 
• 79-22-1 methyl chloroformate 

Relevant academic research and scientific papers

SPIRO COMPOUNDS AS MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF

Described herein are compounds of Formula I and their pharmaceutically acceptable salts, wherein R1, R2, R3, X1, Y1, Y2, Y3, Y4 and Y5 are defined herein; their use as MC4R antagonists; pharmaceutical compositions containing such compounds and salts; the use of such compounds and salts to treat, for example, cachexia, anorexia, or anorexia nervosa; and intermediates and processes for preparing such compounds and salts.

Pyridineacetamide derivative serving as CDK inhibitor, and preparation method and application thereof

The invention belongs to the technical field of pyridineacetamide derivatives, and particularly relates to a pyridineacetamide derivative serving as a CDK inhibitor and a preparation method and application of the pyridine acetamide derivative. The pyridineacetamide derivative shows excellent CDK9/CDK7 enzyme inhibitory activity, and can be used for preparing drugs used for treating cancers, especially hematologic cancers including acute myeloid leukemia, multiple myeloma, chronic lymphocytic leukemia, follicular lymphoma and the like and solid tumors such as breast cancer, prostate cancer, ovarian cancer, hepatocellular carcinoma, pancreatic cancer, kidney cancer, stomach cancer, colorectal cancer, lung cancer and the like.

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES AS GLUTAMINASE INHIBITORS FOR TREATING CANCERS THEREOF

Provided are compounds of formula (I), wherein X, Y, Z, W, m, n, o, p, R1, R2 and R6 are defined as in the description. Pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof are also provided.